Cleveland Clinic Innovations

💡Join our first webinar, Small Molecule Therapeutics for Castration Resistant Prostate Cancer! We’re thrilled to invite you to the inaugural session of our webinar series, "Innovation in Action: Revolutionizing Healthcare". This series is your gateway to exploring transformative technologies and pioneering advancements in medical research. 🗓️ Date: Monday, September 9, 2024 🕒 Time: 1:00 - 1:45 p.m. ET 📍 Location: Virtual – Register now! https://hubs.li/Q02MNddY0 Join Shaun Stauffer, PhD, and Nima Sharifi, MD, as they delve into the cutting-edge development of new therapeutics for castration-resistant prostate cancer. Discover how novel enzymes are being identified as targets for small molecule inhibitors, and learn about the latest advancements in drug candidates aimed at improving patient outcomes. 🔬 What to Expect: - In-depth exploration of new therapeutic approaches. - Insights into pioneering research and development. - Open forum Q&A: Get your questions answered by our experts. This is a unique opportunity to engage with leading scientists and be at the forefront of healthcare innovation. Don’t miss out on this chance to gain valuable knowledge and connect with thought leaders in the field. #HealthcareInnovation #ProstateCancer #SmallMoleculeTherapeutics #Webinar #MedicalResearch #ClevelandClinic #ClevelandClinicInnovations

Strolll , known for its innovative augmented reality platform for neurological conditions, has teamed up with Cleveland Clinic to usher in a new era of medical advancement! This collaboration aims to leverage cutting-edge technology to enhance patient care and potentially expand its therapy services to patients' homes. The United Kingdom's National Health Service (NHS) serves a population of 68 million and spent £239 billion in 2023, making up 11.1% of the gross national product. This presents both opportunities and challenges for health tech startups like Strolll, which, despite initial financial hurdles, has successfully collaborated with the NHS and Cleveland Clinic. This milestone underscores the growing collaboration between U.K. startups and major healthcare institutions. The support from the NHS has been instrumental in Strolll’s journey, demonstrating how public health systems can drive innovation and provide crucial backing to emerging technologies. The $3 million agreement involves Cleveland Clinic acquiring an equity stake in Strolll; a therapeutic tool created by Cleveland Clinic will be incorporated into the Stroll platform. Learn more about the details of the collaboration, including recent coverage by Forbes: https://hubs.li/Q02MzSSX0 #HealthcareInnovation #Partnership #TechInHealth

Congratulations to XII Medical, a Cleveland Clinic Innovations portfolio company, for successfully closing a $45 million Series B equity financing round! This milestone will accelerate the development of their cutting-edge neuromodulation therapy for obstructive sleep apnea (OSA), aiming to offer millions of individuals a revolutionary alternative to current treatments. Funding was led by Omega Funds and joined by new investor Intuitive Ventures and existing investors, including founding investor Cleveland Clinic. https://hubs.li/Q02Mnz_x0 #HealthcareInnovation #SleepApnea #InvestmentNews #ClevelandClinicInnovations

Cardiovascular care has the potential to be transformed by innovation! In a recent article authored by Bernardo Perez Villa, MD, MSc, Senior Engagement Partner, Innovations, Florida Market, highlights three technologies in development with Cleveland Clinic Innovations that are poised to reshape how we address cardiovascular diseases. “It is vital to keep up with cutting-edge developments in the dynamic field of cardiovascular medicine, and many startups armed with pre-market technologies are ready to transform cardiovascular healthcare,” shared Dr. Perez-Villa. “Here, we present three promising technologies that may reshape how we address cardiovascular diseases.” Cleveland Clinic Innovations portfolio companies Advanced NanoTherapies, Inc, Cardionomic Inc., and Mitria Medical, are featured. These innovations represent a significant leap forward in cardiovascular medicine, promising to improve patient care and outcomes. 💓 https://hubs.li/Q02Mc8nN0 #CardiovascularCare #MedicalInnovation #HealthcareTechnology #PatientOutcomes #ClevelandClinic

Learn about groundbreaking research on Alzheimer’s disease and a first-in-class drug in the latest installment of our Inventor Chronicle series! Dianne Perez, PhD and Shaun Stauffer, PhD, levered their expertise and have achieved a major milestone in Alzheimer's research by developing a pioneering drug that activates a specific brain receptor. Their innovative use of green fluorescent protein to track receptor activity and their approach to allosteric signaling have led to a promising new treatment for the debilitating disease. This groundbreaking work offers fresh insights into Alzheimer's pathology and progression, bringing renewed hope to millions affected by the disease. Learn more about this partnership for patient impact and advancement on drug discovery: https://hubs.li/Q02Mc8k00 Want to learn more about transformative power of technologies developed at Cleveland Clinic? Check out the exciting topics in our upcoming webinar series, Innovation In Action: Revolutionizing Healthcare: https://hubs.li/Q02Mc7Qh0 #Alzheimers #DrugDiscovery #HealthcareInnovation #Research #ClevelandClinic #ClevelandClinicInnovations

We are honored to be nominated as a finalist in the Greater Cleveland Partnership's Best of Tech 2024 "HealthTech of the Year" Award! Congratulations to all the talented finalists who are bringing innovative tech solutions and furthering tech education in this great city. 💚 #CLE #MediViewXR #augmentedreality